Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
South Korea
· Delayed Price · Currency is KRW 84,200
+1,200 (1.45%)
Mar 10, 2026, 10:30 AM KST
KRX:185750 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 1,093,614 | 1,178,982 | 1,665,713 | 1,001,820 | 1,312,265 | 2,572,969 | Upgrade
|
| Market Cap Growth | 0.73% | -29.22% | 66.27% | -23.66% | -49.00% | 145.08% | Upgrade
|
| Enterprise Value | 1,171,222 | 1,062,300 | 1,643,506 | 1,090,150 | 1,317,515 | 2,555,288 | Upgrade
|
| Last Close Price | 83000.00 | 89000.00 | 123206.25 | 72988.82 | 92946.29 | 179136.40 | Upgrade
|
| PE Ratio | 18.44 | 10.81 | 7.84 | 12.38 | 30.72 | 28.08 | Upgrade
|
| Forward PE | 16.38 | 14.47 | 18.84 | 11.98 | 14.96 | 28.32 | Upgrade
|
| PS Ratio | 0.65 | 0.74 | 1.00 | 0.67 | 0.98 | 1.98 | Upgrade
|
| PB Ratio | 1.16 | 1.32 | 2.04 | 1.61 | 2.32 | 4.67 | Upgrade
|
| P/TBV Ratio | 1.27 | 1.44 | 2.18 | 1.68 | 2.41 | 4.83 | Upgrade
|
| P/FCF Ratio | - | 45.67 | 6.02 | 43.87 | - | 35.89 | Upgrade
|
| P/OCF Ratio | 95.72 | 18.34 | 5.24 | 14.79 | 101.70 | 24.66 | Upgrade
|
| PEG Ratio | - | 8.17 | 8.17 | 8.17 | 8.17 | 8.17 | Upgrade
|
| EV/Sales Ratio | 0.70 | 0.67 | 0.98 | 0.73 | 0.98 | 1.96 | Upgrade
|
| EV/EBITDA Ratio | 10.87 | 7.63 | 5.80 | 7.60 | 10.78 | 17.30 | Upgrade
|
| EV/EBIT Ratio | 18.34 | 10.68 | 6.67 | 9.92 | 13.90 | 20.62 | Upgrade
|
| EV/FCF Ratio | -9.45 | 41.15 | 5.93 | 47.74 | - | 35.65 | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.21 | 0.27 | 0.38 | 0.42 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 1.96 | 1.35 | 0.77 | 1.64 | 1.94 | 0.92 | Upgrade
|
| Debt / FCF Ratio | - | 7.29 | 0.79 | 10.32 | - | 1.90 | Upgrade
|
| Net Debt / Equity Ratio | 0.08 | -0.13 | -0.18 | 0.13 | 0.09 | -0.05 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.69 | -0.82 | -0.51 | 0.56 | 0.41 | -0.17 | Upgrade
|
| Net Debt / FCF Ratio | -0.60 | -4.42 | -0.52 | 3.50 | -1.41 | -0.36 | Upgrade
|
| Asset Turnover | 1.13 | 1.11 | 1.32 | 1.37 | 1.35 | 1.49 | Upgrade
|
| Inventory Turnover | 3.10 | 3.43 | 3.79 | 3.82 | 4.13 | 4.87 | Upgrade
|
| Quick Ratio | 1.00 | 1.63 | 1.32 | 1.16 | 1.30 | 1.19 | Upgrade
|
| Current Ratio | 1.89 | 2.61 | 1.85 | 1.91 | 2.08 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 6.47% | 13.02% | 29.73% | 13.47% | 7.58% | 17.61% | Upgrade
|
| Return on Assets (ROA) | 2.67% | 4.35% | 12.20% | 6.33% | 5.94% | 8.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.57% | 13.69% | 31.79% | 13.74% | 8.73% | 17.92% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.00% | 9.10% | 27.70% | 14.60% | 13.00% | 19.80% | Upgrade
|
| Earnings Yield | 5.42% | 9.25% | 12.76% | 8.08% | 3.26% | 3.56% | Upgrade
|
| FCF Yield | -11.33% | 2.19% | 16.63% | 2.28% | -2.69% | 2.79% | Upgrade
|
| Dividend Yield | 1.28% | 1.24% | - | - | - | - | Upgrade
|
| Payout Ratio | 23.33% | 12.22% | 5.46% | 13.88% | 25.30% | 10.12% | Upgrade
|
| Buyback Yield / Dilution | 5.39% | 5.20% | -3.79% | 1.77% | 0.73% | 0.06% | Upgrade
|
| Total Shareholder Return | 6.68% | 6.43% | -3.79% | 1.77% | 0.73% | 0.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.